62 unknown. 62 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 62 | Unknown 62 |
Follow Gastroenteritis: new trials by email Literature Review of Gastroenteritis trials Research Report on Gastroenteritis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Jinghua Weikang Capsule in the Treatment of Reflux Esophagitis jinghua weikang capsule - Reflux Esophagitis | Phase 4 | Unknown | The First Affiliated Hospital of Dalian Medical University | 260 | 2023-10-01 | 2023-09-28 |
| Impact of a New Plant-based High-energy Oral Nutritional Supplement on Nutritional Outcomes in Malnourished Patients Fortimel - Malnutrition, Cancer | Phase 4 | Unknown | Danone Specialized Nutrition | 140 | 2023-08-09 | 2023-09-26 |
| Pharmacokinetic Infliximab Data in Pediatric Crohn's Disease Infliximab - Crohn Disease, Child, Only | Phase 4 | Unknown | Erasmus Medical Center | 50 | 2023-08-02 | 2024-09-19 |
| SIIT Based on UST CDST in Patients With CD selective intensive induction therapy based on ustekinumab clinical decision-making tools - Crohn Disease | Phase 4 | Unknown | Sixth Affiliated Hospital, Sun Yat-sen University | 140 | 2023-06-01 | 2023-07-24 |
| Saffron as Anti Inflammatory In Patients With Inflammatory Bowel Disease Saffron, Placebo - Ulcerative Colitis | Phase 4 | Unknown | Minia University | 90 | 2023-03-30 | 2023-03-17 |
| Subcutaneous Interval Lengthening of Vedolizumab for Economic Research Vedolizumab Injection - Inflammatory Bowel Diseases | Phase 4 | Unknown | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 40 | 2023-02-09 | 2024-09-04 |
| Effect of Oral N-Acetyl Cysteine in Prevention of Necrotizing Enterocolitis in Preterm Neonates With Feeding Intolerance oral n-acetyl cysteine, placebo - Preterm Neonates and Feeding Intolerance, Necrotizing Enterocolitis | Phase 4 | Unknown | Ain Shams University | 100 | 2023-01-01 | 2024-01-12 |
| Predicting Response to Iron Supplementation in Patients With Active Inflammatory Bowel Disease Intravenous iron, Ferric maltol, Ferrous fumarate - Inflammatory Bowel Diseases, Iron-deficiency | Phase 4 | Unknown | Leiden University Medical Center | 90 | 2022-08-19 | 2023-03-31 |
| OZOCLO_MUCOSITIS: a New Protocol for Prevention of Oral Mucositis 1. alpha acid lipoic - tables, 2. ozonated oil - mouthwash, 3. chlorhexidine 0,2% - mouthwash - Mucositis (MeSH Unique ID: D052016), Stomatitis (MeSH Unique ID: D013280) | Phase 4 | Unknown | University of Palermo | 80 | 2022-03-10 | 2022-01-27 |
| Early Proactive Therapeutic Drug Monitoring of Infliximab in Children: EPIC Study Infliximab - Inflammatory Bowel Diseases | Phase 4 | Unknown | IRCCS Burlo Garofolo | 86 | 2022-03-09 | 2023-08-18 |
| Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy Eupatilin, Rebamipide - Rheumatoid Arthritis, Osteoarthritis | Phase 4 | Unknown | Seoul National University Boramae Hospital | 50 | 2021-06-01 | 2021-05-13 |
| Proton Pump Inhibitor (PPI) Response in Eosinophilic Esophagitis Assessed by Transnasal Endoscopy (TNE) Omeprazole 20mg BID - Eosinophilic Esophagitis | Phase 4 | Unknown | University of Colorado, Denver | 90 | 2020-10-07 | 2024-07-03 |
| Control Crohn Safe Trial Adalimumab, standard step-up care - Crohn Disease, Inflammatory Bowel Diseases | Phase 4 | Unknown | Maastricht University Medical Center | 158 | 2019-12-23 | 2022-09-07 |
| Adherence of a 1.600 mg Single Tablet 5-ASA Treatment of Ulcerative Colitis Mesalazine - Ulcerative Colitis | Phase 4 | Unknown | Flemming Bendtsen | 200 | 2019-11-28 | 2023-09-26 |
| Can Vitamin D Supplementation in People With Crohn's Disease Improve Symptoms as an Adjunct Therapy? Cholecalciferol - Crohn Disease, Vitamin D Deficiency | Phase 4 | Unknown | University Hospital Birmingham NHS Foundation Trust | 50 | 2019-09-17 | 2020-03-26 |
| Zinc Supplementation on Very Low Birth Weight Infant Zinc Sulfate, Placebos - Early-Onset Sepses, Neonatal, Periventricular Haemorrhage Neonatal | Phase 4 | Unknown | Fakultas Kedokteran Universitas Indonesia | 364 | 2019-08-20 | 2019-08-15 |
| Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis Vedolizumab - Ulcerative Colitis | Phase 4 | Unknown | Guy's and St Thomas' NHS Foundation Trust | 30 | 2019-07-01 | 2019-07-08 |
| The Effects of Parenteral ω-3 Polyunsaturated Fatty Acid on Postoperative Complications of Patients With Crohn's Disease ω-3 polyunsaturated fatty acid, Intestinal surgery for Crohn's Disease - Crohn Disease | Phase 4 | Unknown | Sir Run Run Shaw Hospital | 158 | 2019-03-01 | 2019-04-03 |
| EoE RCT Fluticasone and Omeprazole vs Fluticasone Alone Retrospective evaluation of endoscopy prior to study drug, Symptom Survey, Medication Compliance Phone Call - Eosinophilic Esophagitis | Phase 4 | Unknown | Claire Daniels | 100 | 2018-10-02 | 2018-12-20 |
| Optimization of Golimumab Treatment in Ulcerative Colitis Golimumab 50 mg in patients <80 kg and Golimumab 100 mg in patients >80 kg, Golimumab treatment optimization. - Colitis, Ulcerative | Phase 4 | Unknown | Hospital de Manises | 50 | 2018-10-01 | 2018-09-13 |
Showing 20 of 62. Sign in to see all of them.
Crohn Disease (23) · Colitis, Ulcerative (16) · Inflammatory Bowel Diseases (15) · Appendicitis (3) · Enterocolitis, Necrotizing (3) · Anemia, Iron-Deficiency (2) · Bone Diseases, Metabolic (2) · Diverticulitis (2) · Diverticulitis, Colonic (2) · Eosinophilic Esophagitis (2) · Esophagitis (2) · Gastritis (2) · Heartburn (2) · Mucositis (2) · Stomach Ulcer (2)
Digestive System Diseases (62) · Gastrointestinal Diseases (61) · Intestinal Diseases (54) · Inflammatory Bowel Diseases (26) · Colonic Diseases (19) · Colitis (16) · Pathological Conditions, Signs and Symptoms (12) · Nutritional and Metabolic Diseases (7) · Pathologic Processes (7) · Hemic and Lymphatic Diseases (6) · Infections (6) · Signs and Symptoms (6) · Hematologic Diseases (5) · Immune System Diseases (5)
golimumab (4) · Infliximab (3) · Omeprazole (3) · Probiotics (3) · Adalimumab (2) · Amoxicillin (2) · Amoxicillin-Potassium Clavulanate Combination (2) · Appendectomy (2) · Certolizumab Pegol (2) · Cholecalciferol (2) · Ertapenem (2) · Hydrocortisone (2) · Mesalamine (2) · rebamipide (2) · vedolizumab (2)
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2) · American University of Beirut Medical Center (2) · Federal University of Juiz de Fora (2) · Istituto Clinico Humanitas (2) · The Baruch Padeh Medical Center, Poriya (2) · A.O. Ospedale Papa Giovanni XXIII (1) · Ain Shams University (1) · Ascension Health (1) · Atlanta Gastroenterology Associates (1) · Belarusian Medical Academy of Post-Graduate Education (1) · Chang Gung Memorial Hospital (1) · Claire Daniels (1) · Copenhagen University Hospital at Herlev (1) · Danone Specialized Nutrition (1) · Erasmus Medical Center (1)
Netherlands (7) · United States (7) · China (6) · Italy (6) · Israel (3) · United Kingdom (3) · Denmark (2) · Egypt (2) · Germany (2) · Lebanon (2) · Spain (2) · Australia (1) · Belarus (1) · Belgium (1) · Brazil (1)
Arnon Blum, MD (1) · Bikash Medhi, MD (1) · Bronte Holt, MBBS PhD (1) · Carla VA Antunes, MSc. MD (1) · David Branski, MD (1) · Douglas C Wolf, MD (1) · Emily Wright, MBBS PhD (1) · Erasmo Miele, Assistant Professor (1) · Ernst van Heurn, MD PhD (1) · Ferdinand Koeckerling, Prof. Dr. (1) · Fergal Donnellan, MD (1) · Flemming Bendtsen, MDSci (1) · Frank M Ruemmele, MD PhD (1)
PMID 10049409, PMID 16329022, PMID 17919504, PMID 18721738, PMID 19116333, PMID 19135997, PMID 19209273, PMID 19535182, PMID 20920599, PMID 2179802, PMID 23567357, PMID 23878167, PMID 24063425, PMID 24328943, PMID 24494987, PMID 24572205, PMID 25168749, PMID 25574111, PMID 25576753, PMID 25705682, PMID 25836986, PMID 25857665, PMID 26063325, PMID 26142551, PMID 26245216, PMID 26247167, PMID 26363929, PMID 26426817, PMID 26513622, PMID 26685124, PMID 26765407, PMID 27104192, PMID 27686365, PMID 28075506, PMID 28107279, PMID 28406440, PMID 28607547, PMID 29146647, PMID 30009819, PMID 30564993, PMID 30708107, PMID 32461297, PMID 32786044, PMID 33743801, PMID 33947729, PMID 34890567, PMID 35935714, PMID 36736339, PMID 37310877, PMID 38296290
2009 (1), 2016 (1), 2018 (1)